10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference
10x Genomics (Nasdaq: TXG), a pioneer in single cell and spatial biology, has announced its upcoming participation in the BofA Securities 2025 Healthcare Conference. The company's management team will engage in a fireside chat scheduled for Tuesday, May 13, at 11:20 a.m. Pacific Time.
Investors and interested parties can access the event through a live webcast available on the company's investor relations website at investors.10xgenomics.com. For those unable to attend the live session, the webcast recording will remain accessible for a minimum of 30 days following the event.
10x Genomics (Nasdaq: TXG), pioniere nella biologia cellulare singola e spaziale, ha annunciato la sua prossima partecipazione alla BofA Securities 2025 Healthcare Conference. Il team di gestione dell'azienda parteciperà a una conversazione informale prevista per martedì 13 maggio alle 11:20 ora del Pacifico.
Investitori e interessati potranno seguire l'evento tramite un webcast in diretta disponibile sul sito web delle relazioni con gli investitori all'indirizzo investors.10xgenomics.com. Per chi non potesse partecipare alla sessione live, la registrazione del webcast sarà accessibile per almeno 30 giorni dopo l'evento.
10x Genomics (Nasdaq: TXG), pionero en biología celular única y espacial, ha anunciado su próxima participación en la Conferencia de Salud 2025 de BofA Securities. El equipo directivo de la compañía participará en una charla informal programada para el martes 13 de mayo a las 11:20 a.m., hora del Pacífico.
Los inversores y personas interesadas podrán acceder al evento mediante una transmisión en vivo disponible en el sitio web de relaciones con inversores de la compañía en investors.10xgenomics.com. Para quienes no puedan asistir en vivo, la grabación de la transmisión estará disponible por al menos 30 días después del evento.
10x Genomics (나스닥: TXG)는 단일 세포 및 공간 생물학 분야의 선구자로서, BofA Securities 2025 헬스케어 컨퍼런스에 곧 참여할 예정임을 발표했습니다. 회사 경영진은 5월 13일 화요일 태평양 시간 오전 11시 20분에 예정된 비공식 대화에 참여할 것입니다.
투자자 및 관심 있는 분들은 회사 투자자 관계 웹사이트 investors.10xgenomics.com에서 제공되는 라이브 웹캐스트를 통해 행사를 시청할 수 있습니다. 라이브 세션에 참석하지 못하는 분들을 위해 웹캐스트 녹화본은 행사 후 최소 30일간 이용 가능합니다.
10x Genomics (Nasdaq : TXG), pionnier dans la biologie cellulaire unique et spatiale, a annoncé sa prochaine participation à la conférence Healthcare 2025 de BofA Securities. L'équipe de direction de l'entreprise participera à une discussion informelle prévue le mardi 13 mai à 11h20, heure du Pacifique.
Les investisseurs et les parties intéressées pourront accéder à l'événement via un webcast en direct disponible sur le site des relations investisseurs de la société à l'adresse investors.10xgenomics.com. Pour ceux qui ne peuvent pas assister en direct, l'enregistrement du webcast restera accessible pendant au moins 30 jours après l'événement.
10x Genomics (Nasdaq: TXG), ein Pionier in der Einzelzell- und Raum-Biologie, hat seine bevorstehende Teilnahme an der BofA Securities 2025 Healthcare Conference angekündigt. Das Management-Team des Unternehmens wird an einem Fireside-Chat teilnehmen, der für Dienstag, den 13. Mai, um 11:20 Uhr Pazifikzeit geplant ist.
Investoren und Interessierte können die Veranstaltung über einen Live-Webcast verfolgen, der auf der Investor-Relations-Website des Unternehmens unter investors.10xgenomics.com verfügbar ist. Für diejenigen, die nicht live teilnehmen können, bleibt die Aufzeichnung des Webcasts mindestens 30 Tage nach der Veranstaltung zugänglich.
- Management's participation in a major healthcare conference indicates continued market visibility and investor relations efforts
- None.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X (Twitter), Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-participate-in-the-bofa-securities-2025-healthcare-conference-302441921.html
SOURCE 10x Genomics, Inc.